Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems.

siRNA delivery remains a major challenge in RNAi-based therapy. Here, we report for the first time that an amphiphilic dendrimer is able to self-assemble into adaptive supramolecular assemblies upon interaction with siRNA, and effectively delivers siRNAs to various cell lines, including human primary and stem cells, thereby outperforming the currently available nonviral vectors. In addition, this amphiphilic dendrimer is able to harness the advantageous features of both polymer and lipid vectors and hence promotes effective siRNA delivery. Our study demonstrates for the first time that dendrimer-based adaptive supramolecular assemblies represent novel and versatile means for functional siRNA delivery, heralding a new age of dendrimer-based self-assembled drug delivery in biomedical applications.

[1]  Sarah Crunkhorn.  Trial watch: Pioneering RNAi therapy shows antitumour activity in humans , 2013, Nature Reviews Drug Discovery.

[2]  Maurizio Fermeglia,et al.  Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection. , 2011, Molecular pharmaceutics.

[3]  M. Klein,et al.  Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes and Other Complex Architectures , 2010, Science.

[4]  Sangdun Choi,et al.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.

[5]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[6]  C. Liu,et al.  An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo. , 2012, Angewandte Chemie.

[7]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[8]  M. Gleave,et al.  Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer , 2004, Cancer Research.

[9]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[10]  Ernst Wagner,et al.  Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. , 2012, Accounts of chemical research.

[11]  M. Gleave,et al.  Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. , 2005, Cancer research.

[12]  Ling Peng,et al.  Dendrimers as non-viral vectors for siRNA delivery , 2012 .

[13]  Yu-cheng Tseng,et al.  Lipid-based systemic delivery of siRNA. , 2009, Advanced drug delivery reviews.

[14]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[15]  J. Lieberman,et al.  siRNA-directed inhibition of HIV-1 infection , 2002, Nature Medicine.

[16]  Sabrina Pricl,et al.  Less is more – multiscale modelling of self-assembling multivalency and its impact on DNA binding and gene delivery , 2010 .

[17]  R. Einspanier,et al.  Glycine-terminated dendritic amphiphiles for nonviral gene delivery. , 2012, Biomacromolecules.

[18]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.